Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Dorna Therapeutics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Dorna Therapeutics

Dorna Therapeutics

Seed

Dorna Therapeutics: Pioneering universal cancer vaccines for lasting immunity via targeted tumor treatment.

HQ
Cambridge, MA, US
Founded
2018
Overview
Compare
Fundraising
Employees

Dorna Therapeutics aims to revolutionize cancer treatment by developing a universal therapeutic cancer vaccine. Their innovative approach stimulates both innate and adaptive immune responses directly within solid tumors, utilizing a single drug compound with tumor-accumulating capabilities. This method enables patients to immunize themselves against their cancers, offering a long-lasting curative effect.

Dorna Therapeutics has made significant strides in the field of oncology, positioning itself as a pioneer in cancer immunotherapy. Their groundbreaking work has the potential to transform cancer treatment paradigms, providing a more effective and enduring solution for patients worldwide.

Dorna Therapeutics - Similar Companies

Mana Therapeutics logo

Mana Therapeutics

Photonpharma logo

Photonpharma

photonpharma.net

Umoja Biopharma logo

Umoja Biopharma

Imvaq Therapeutics logo

Imvaq Therapeutics

Palm Therapeutics logo

Palm Therapeutics

Cancervax logo

Cancervax

cancervax.com

Adventris Pharmaceuticals logo

Adventris Pharmaceuticals

GO Therapeutics logo

GO Therapeutics

gotherapeutics.com

Surge Therapeutics logo

Surge Therapeutics

surgetx.com

Irazu Oncology logo

Irazu Oncology

irazuoncology.com

Werewolf Therapeutics logo

Werewolf Therapeutics

werewolftx.com

EpiVax Oncology logo

EpiVax Oncology

epivaxtx.com

Seneca Therapeutics logo

Seneca Therapeutics

Onchilles Pharma logo

Onchilles Pharma

Immunophotonics logo

Immunophotonics

Dorna Therapeutics - Quick Facts

Who are Dorna Therapeutics' competitors?

Companies similar to Dorna Therapeutics include Mana Therapeutics, Photonpharma, Umoja Biopharma and Imvaq Therapeutics.

When was Dorna Therapeutics founded?

Dorna Therapeutics was founded in 2018.

Where is Dorna Therapeutics' headquarters located?

Dorna Therapeutics' headquarters is located in Cambridge, MA, US.

When was Dorna Therapeutics' last funding round?

Dorna Therapeutics' most recent funding round was for $300k (USD) in July 2018.

How much has Dorna Therapeutics raised to-date?

As of Jul 18, 2018, Dorna Therapeutics has raised a total of $300k (USD).

How many employees does Dorna Therapeutics have?

Dorna Therapeutics has 1 employee as of Feb 5, 2024.

Dorna Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Vaccines
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified